Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Linton

Showing results (241-250 of 265) with videos related to

Pageof 27
Sort By:
Haematologica|March 5, 2026
Epcoritamab plus rituximab, dexamethasone, cytarabine, oxaliplatin/carboplatin induces deep and durable responses in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma: results from the EPCORE NHL-2 trialPau Abrisqueta, Yasmin H Karimi, Daniel Morillo, et al.
Blood Advances|September 11, 2020
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphomaStephen Booth, Hannah Plaschkes, Amy A Kirkwood, et al.
American Journal of Public Health|February 1, 1971
Report of the committee on environment, 1970W E Gilbertson, R Angelotti, C M Berry, et al.
Blood Advances|November 15, 2023
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experienceRohan Shotton, Rachel Broadbent, Alia Alchawaf, et al.
Blood Advances|September 8, 2023
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA studyStephen Opat, Alessandra Tedeschi, Bei Hu, et al.
Blood Advances|August 31, 2021
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trialChristopher P Fox, Ayesha S Ali, Graham McIlroy, et al.
Neuromuscular Disorders : NMD|January 15, 2017
Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophyRoxanna M Bendixen, Jocelyn Butrum, Mina S Jain, et al.
Parasites & Vectors|February 26, 2013
Phylogeography of the neotropical Anopheles triannulatus complex (Diptera: Culicidae) supports deep structure and complex patternsMarta Moreno, Sara Bickersmith, Wesley Harlow, et al.
BMJ Global Health|February 10, 2025
Observational research in epidemic settings: a roadmap to reformEmily E Ricotta, Fausto A Bustos Carrillo, Samuel Angelli-Nichols, et al.
Leukemia|September 25, 2024
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trialCatherine Thieblemont, Yasmin H Karimi, Herve Ghesquieres, et al.
Pageof 27

Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
Haematologica|March 5, 2026
Epcoritamab plus rituximab, dexamethasone, cytarabine, oxaliplatin/carboplatin induces deep and durable responses in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma: results from the EPCORE NHL-2 trialPau Abrisqueta, Yasmin H Karimi, Daniel Morillo, et al.
Blood Advances|September 11, 2020
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphomaStephen Booth, Hannah Plaschkes, Amy A Kirkwood, et al.
American Journal of Public Health|February 1, 1971
Report of the committee on environment, 1970W E Gilbertson, R Angelotti, C M Berry, et al.
Blood Advances|November 15, 2023
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experienceRohan Shotton, Rachel Broadbent, Alia Alchawaf, et al.
Blood Advances|September 8, 2023
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA studyStephen Opat, Alessandra Tedeschi, Bei Hu, et al.
Blood Advances|August 31, 2021
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trialChristopher P Fox, Ayesha S Ali, Graham McIlroy, et al.
Neuromuscular Disorders : NMD|January 15, 2017
Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophyRoxanna M Bendixen, Jocelyn Butrum, Mina S Jain, et al.
Parasites & Vectors|February 26, 2013
Phylogeography of the neotropical Anopheles triannulatus complex (Diptera: Culicidae) supports deep structure and complex patternsMarta Moreno, Sara Bickersmith, Wesley Harlow, et al.
BMJ Global Health|February 10, 2025
Observational research in epidemic settings: a roadmap to reformEmily E Ricotta, Fausto A Bustos Carrillo, Samuel Angelli-Nichols, et al.
Leukemia|September 25, 2024
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trialCatherine Thieblemont, Yasmin H Karimi, Herve Ghesquieres, et al.
Pageof 27